학술논문

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
Document Type
Artikel
Source
NPJ breast cancer. 7(1):2
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
2374-4677